US$ 25.00
dsip doses 5mg — 5mg/vial Reference Standard DSIP, BPC-157, CJC (Sleep Blend)
Description
The novel triple-agonist mechanism means less long-term safety data is available

In essence, a warning letter represents the FDAs final step before taking severe action

The study is being conducted by Dr Douglas Samuel, Gastroenterologist at Bankstown-Lidcombe Hospital

27 As numerous studies have been conducted on drug delivery systems, attempts to exogenously deliver NO and other gaseous signaling molecules as therapeutic agents are increasing
